AzTrials
AzTrials

Binocular Vision DisorderNCT05633212

Binocular Vision Alternations and fMRI Activation After ICL Implantation for High Myopia

An observational study of Binocular Vision Disorder, run by Zhongshan Ophthalmic Center, Sun Yat-sen University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Implantable collamer lens (ICL) is one of the most effective operation for high myopia. Due to refractive correction changed, and prism effect of the spectacle removed, in the early stage after ICL implantation, binocular function might be dysfunction, leading to asthenopia, blurred vision, double vision and so on. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Binocular Vision Disorder
How many people
50 participants
Where
1 siteChina
Study dates
15 Mar 2022to 30 Jun 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: The high myopia subjects that scheduled for ICL implantation from Zhongshan Ophthalmic Center, Sun Yat-sen University

Who may be able to join

  • Age 18-35
  • Spherical equivalent over -6.00DS, astigmatism within -2.00DC, anisometropia within -2.00DS
  • BCVA ≥ 0.8
  • Plan to accept implantable collamer lens surgery
  • Near point of convergence within 10cm
  • Positive fusion vergence over 20pd

Who cannot join

  • Stabismus
  • Previous ocular surgery or trauma
  • History of vision therapy
  • Monovision and nystagmus
  • Mental disease or craniocerebral trauma

Trial locations and contacts

1 site in 1 country.

Yehong Zhuo, doctor contact

13352828998

zhuoyh@mail.sysu.edu.cn

Junxiong Lin, Master contact

13902338172

linjunxiong@gzzoc.com

China1 site, 1 recruiting
  • Zhongshan Ophthalmic Center, Sun Yat-sen University

    Guangzhou, Guangdong, 510060

    Recruiting

Other trials in China

About this study

Official title: Binocular Vision Alternations and Functional Magnetic Resonance Imaging Activation After Implantable Collamer Lens Implantation for High Myopia

Implantable collamer lens (ICL) is one of the most effective operation for high myopia. Due to refractive correction changed, and prism effect of the spectacle removed, in the early stage after ICL implantation, binocular function might be dysfunction, leading to asthenopia, blurred vision, double vision and so on. This study will recruit the high myopia subjects that scheduled for ICL implantation, purpose to investigate the binocular vision alternations and brain activation that impacted by ICL implantation.

Keywords
binocular vision, accommodation, vergence, fMRI

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes of phoria at different time points

    Phoria was measured by phoropter.

    Measured: The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.

  2. Changes of AC/A at different time points

    Gradient AC/A was measured by phoropter.

    Measured: The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.

  3. Changes of fusion vergence at different time points

    Fusion vergence was measured by phoropter.

    Measured: The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.

  4. Changes of accommodative response at different time points

    Accommodative response was measured using monocular estimated method.

    Measured: The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.

  5. Changes of relative accommodation at different time points

    Relative accommodation was measured by phoropter.

    Measured: The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.

  6. Changes of near point of convergence at different time points

    Near point of convergence was measured using push-up method.

    Measured: The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.

  7. Changes of accommodation amplitude at different time points

    Accommodative amplitude was measured using push-up method.

    Measured: The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.

  8. Changes of vergence facility at different time points

    Vergence facility was measured by +2.00D/-2.00D flipper.

    Measured: The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.

  9. Changes of accommodative facility at different time points

    Accommodative facility was measured by 3△BI/12△BO flipper.

    Measured: The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.

Secondary outcomes (1)
  1. Changes of brain activation at different time points

    Functional magnetic resonance imaging activation of the brain

    Measured: The examination was performed before operation and 1 month, 6 monthes after ICL implantation.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Dec 2022
  2. Study start15 Mar 2022
  3. Primary completion30 Jun 2023 (estimated)
  4. Study completion30 Jun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05633212
Sponsor's protocol ID
2022KYPJ198
Status last verified
Mar 2022
First submitted
3 Nov 2022
Last updated
1 Dec 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Zheng K, Han T, Zhou X. Accommodative changes after SMILE for moderate to high myopia correction. BMC Ophthalmol. 2016 Oct 4;16(1):173. doi: 10.1186/s12886-016-0352-8.

    PubMed 27716112
  • Han J, Hong S, Lee S, Kim JK, Lee HK, Han SH. Changes in fusional vergence amplitudes after laser refractive surgery for moderate myopia. J Cataract Refract Surg. 2014 Oct;40(10):1670-5. doi: 10.1016/j.jcrs.2014.01.043. Epub 2014 Aug 20.

    PubMed 25149555
  • Tsujimoto K, Mizuno K, Nishida D, Tahara M, Yamada E, Shindo S, Kasuga S, Liu M. Prism adaptation changes resting-state functional connectivity in the dorsal stream of visual attention networks in healthy adults: A fMRI study. Cortex. 2019 Oct;119:594-605. doi: 10.1016/j.cortex.2018.10.018. Epub 2018 Oct 31.

    PubMed 30471844
  • Wilf M, Serino A, Clarke S, Crottaz-Herbette S. Prism adaptation enhances decoupling between the default mode network and the attentional networks. Neuroimage. 2019 Oct 15;200:210-220. doi: 10.1016/j.neuroimage.2019.06.050. Epub 2019 Jun 22.

    PubMed 31233909

Questions about this trial

What is this clinical trial studying?

An observational study of Binocular Vision Disorder, run by Zhongshan Ophthalmic Center, Sun Yat-sen University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yehong Zhuo, doctor (13352828998, zhuoyh@mail.sysu.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes of phoria at different time points (time frame: The examination was performed before operation and 1 week, 1 month, 3 monthes, 6 monthes after ICL implantation.). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05633212, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Dec 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in